TAILIEUCHUNG - Statin use is associated with the reduction in hepatocellular carcinoma recurrence after liver surgery

Hepatocellular carcinoma (HCC) is the sixth most common form of cancer worldwide. Although surgi‑ cal treatments have an acceptable cure rate, tumor recurrence is still a challenging issue. In this meta-analysis, we investigated whether statins prevent HCC recurrence following liver surgery. | Khajeh et al. BMC Cancer 2022 22 91 https s12885-022-09192-1 RESEARCH Open Access Statin use is associated with the reduction in hepatocellular carcinoma recurrence after liver surgery Elias Khajeh1 Arash Dooghaie Moghadam1 Pegah Eslami1 Sadeq Ali Hasan Al Saegh1 Ali Ramouz1 Saeed Shafiei1 Omid Ghamarnejad1 Sepehr Abbasi Dezfouli1 Christian Rupp2 3 Christoph Springfeld3 4 Carlos Carvalho5 Pascal Probst1 Seyed Mostafa Mousavizadeh1 and Arianeb Mehrabi1 3 Abstract Background Hepatocellular carcinoma HCC is the sixth most common form of cancer worldwide. Although surgi cal treatments have an acceptable cure rate tumor recurrence is still a challenging issue. In this meta-analysis we investigated whether statins prevent HCC recurrence following liver surgery. Methods PubMed Web of Science EMBASE and Cochrane Central were searched. The Outcome of interest was the HCC recurrence after hepatic surgery. Pooled estimates were represented as hazard ratios HRs and odds ratios ORs using a random-effects model. Summary effect measures are presented together with their corresponding 95 confi dence intervals CI . The certainty of evidence was evaluated using the Grades of Research Assessment Development and Evaluation GRADE approach. Results The literature search retrieved 1362 studies excluding duplicates. Nine retrospective studies including 44 219 patients 2243 in the statin group and 41 976 in the non-statin group were included in the qualitative analysis. Patients who received statins had a lower rate of recurrence after liver surgery HR 95 CI p Khajeh et al. BMC Cancer 2022 22 91 Page 2 of 9 have acceptable cure rates they also have high recur- excluded. The remaining studies were selected for full- rence rates 8 9 with recurrence in more than 50 of text review by reviewing the titles and abstracts for patients after 5 years of surgery 10 11 . Recurrence rates eligibility. after transplantation are between 8 and 21 despite the use of new .

• Y khoa - Dược
• BMC Cancer
• Hepatocellular carcinoma
• Liver resection
• Liver transplantation
• Meta analysis
• Cancer patient pathways
• Colorectal cancer
• Lung cancer
• Breast cancer
• Prostate cancer
• Ovarian cancer
• Cancer detection
• Ovarian cancer symptoms
• Ovarian cancer signs
• Ovarian cancer tests
• Cancer biomarkers
• Pediatric cancer
• Familial cancer predisposition
• Hereditary cancer syndrome
• Genetic cancer susceptibility
• Advanced cancer
• Biliary tract cancer
• Multimodal intervention
• Pancreatic cancer
• Physical activity
• Breast cancer screening
• Familial breast cancer
• Young breast cancer survivors
• High risk relatives
• Randomized trial
• Childhood cancer
• Childhood cancer survivor
• Thyroid cancer screening
• Secondary cancer
• Cancer screening
• Community awareness
• Cancer education
• Cervical cancer
• Prior cancer
• Cancer survivors
• Cancer registry
• Second cancer
• Surgical oncology
• Cancer imaging
• Radiation oncologists
• Medical oncologists
• Oesophagogastric cancer
• Liver cancer
• Hepatobiliary cancer
• Multidisciplinary rehabilitation
• EGFR mutation
• Family history of cancer
• Inherited susceptibility
• Cancer predisposition genes
• Lung cancer aetiology
• Cancer stem cells
• Oct4 overexpressing lung cancer
• Human lung cancer xenograft model
• Disease free survivals
• Cancer hallmarks
• Cancer genesis
• Defiant disease
• Mutational signature
• Cancer diagnosis
• Cancer genomics
• Molecular medicine
• Whole genome sequencing
• Cancer susceptibility gene
• Breast cancer prognosis
• Next generation sequencing
• Quality of care
• Quality indicators
• Shifting cancer care
• German cancer society
• Colorectal cancer screening
• Stomach cancer screening
• Lung cancer survivor
• Physician recommendation
• Total number of lymph nodes
• Lymph node ratio
• Left colon cancer
• Right colon cancer
• Overall survival
• Cumulative incidence
• Esophageal cancer
• Head and neck cancer
• Metachronous cancer
• Young onset
• Reproductive cancer
• Risk factor
• Early detection of cancer
• Gastric cancer incidence
• Population based specialized registry
• Gastric cancer survival
• Gastric cancer clinical characteristics
• Gastric cancer pathological characteristics
• Lung Cancer Screening
• Racial disparities
• Lung Cancer diagnosis
• Screening adherence
• Second primary colorectal cancer
• Standardized incidence ratio
• Left sided colon cancer
• Right sided colon cancer
• Quality of cancer care
• Population based study